Tags » Novartis » Page 3

California Supreme Court Exposes Drug Makers to Additional Liability

SAN FRANCISCO (AP) — A sharply divided California Supreme Court ruled Thursday that pharmaceutical companies can be held liable for warning labels on generic versions of drugs they once made even after they’ve sold the drugs to other companies and stopped manufacturing them. 517 more words


The First FDA-Approved Gene Therapy Can Cure a Type of Blindness—But May Cost $1 Million

The Food and Drug Administration (FDA) on Tuesday approved the first true gene therapy in the U.S.—Luxturna from Spark Therapeutics, which treats a form of inherited vision loss which can lead to blindness. 334 more words


The High Cost of Living


In August, the U.S. Food and Drug Administration (FDA) approved the first-ever gene-altering treatment for a rare form of childhood leukemia.

This milestone medical breakthrough allows scientists to genetically modify a patient’s own cells to fight cancer, turning them into a “living drug.” 581 more words


New Migraine Drugs May Help Prevent Headaches Before They Start

One in seven Americans suffers from migraines, and medications currently prescribed to prevent them—like blood-pressure drugs and antidepressants—don’t work for many people. But two new studies offer hope for those who haven’t respond well to existing treatments. 831 more words

Novartis Provides Hurricane Relief During Team Building Day

As a healthcare company, Novartis employees are no strangers to helping others. However, their recent team building event in Hanover, NJ helped them discover new ways to put their servitude to good use. 18 more words

Team Building

Gene Therapy Is Revolutionary Science That Can Cure Blindness. Is It Worth $1 Million a Pop?

2017 has been a marquee year for gene therapy and medical technologies which harness—and manipulate—the body’s very biological building blocks to fight disease. But with great innovation comes profound questions about cost. 330 more words


Bill Gates just donated $50 million to look for out-of-the-box Alzheimer's cures

There hasn’t been a new drug approved to treat Alzheimer’s in more than a decade, and Bill Gates is impatient for a cure.

In a blog post published t0day (Nov. 557 more words